Transforming the lives of those living with diabetes and prediabetes

ESME Diabetes Solutions is bridging the gaps for those living with diabetes and prediabetes.

ESME aims to bridge the gaps in this space by developing evidence-based solutions to better manage, and detect earlier, diabetes.

Together with the research undertaken by our research arm - Global Diabetes Research (GDR), ESME develops and commercialises the technology behind a range of innovative products marketed under the ESME brand that have the ability to consistently deliver:

Better diagnosis

Better management

Better health outcomes

ESME-

Everyday Solutions Made Easy!

ESME Diabetes Solutions is the technology behind a range of Diabetes focused products

Created by Credentialed Diabetes Educators with first hand experience of what people with diabetes want and need to feel safe and more confident every day of their lives.

Self administered, Complete hypo treatment

HYPOGLYCAEMIA

A hypo can occur suddenly and without warning. If not treated immediately and effectively, this can become a medical emergency.

There is currently no TGA approved complete oral treatment for hypoglycaemia. GDR is researching and developing an evidence-based, new model of delivery for treating hypos.

A new 2 step delivery system will undergo clinical trials to become the only TGA approved, complete oral treatment on the market, for those living with the risk of hypoglycaemia, as a result of the medication they require to manage their diabetes.

________________

Available in Pharmacies soon

_____________

FIRST TWO STEP HYPO TREATMENT

  • Resolves low glucose levels fast

  • Maintain glucose levels for up to two hour after

  • Convenient and consistent

Point of care device, Earlier detection

INSULIN RESISTANCE

It is current practice to detect prediabetes in those at risk before it progresses to type 2 diabetes. We believe this is too late, and driven by the desire to see better health outcomes and quality of life for those living with or at risk of type 2 diabetes or prediabetes, we believe a point of care (POC) device is needed to provide immediate results at the time of patient consult with GP, or at home using a simple POC device.

A POC medical device is being developed, capable of detecting signs of prediabetes developing up to the 10 years before it can currently be diagnosed.

Evidence indicates this will prevent or prolong prediabetes, gestational diabetes and / or the progression to type 2 diabetes by initiating lifestyle changes, education and timely clinical management.

_____________

Type 2 diabetes risk factors: family history, age (over 30), ethnicity, waist circumference, diet, lifestyle, inactivity, stress, certain medications, history of gestational diabetes, history of poly cystic ovary syndrome.

Available soon

_______________

INSULIN RESISTANCE TEST

  • Detect insulin resistance in its earliest stages

  • Convenient & instant results

  • Earlier detection allows time to delay or prevent type 2 diabetes

  • If you're at risk of diabetes, then so are all your family members

Safer weight loss, Combat side effects

NUTRITIONAL DEFICIENCIES

Of the 1.3 million people living with type 2 diabetes in Australia, approximately 33% of those are taking GLP-1 weight loss medications. The use of such weight loss drugs (typically used for type 2 diabetes), has become increasingly popular for off-label use, and there are growing concerns around the health risks to people being prescribed these drugs.

Due to the known side effect of a decreased appetite, this class of weight loss drugs can result in extremely rapid weight loss, muscle wastage, and nutritional deficiencies.

There is currently no solution to these side effects, and as such ESME, together with the research from GDR, is currently researching a safe solution to mitigate these extreme side effects.

_______________

BE THE FIRST TO KNOW

JOIN OUR MAILING LIST TO BE KEPT UP TO DATE